Intraocular Expression of Serum Amyloid A and Interleukin-6 in Proliferative Diabetic Retinopathy
Authors:
- Yong TaoYTYong Tao
- Qiang LuQLQiang Lu
- Yan-Rong JiangYJYan-Rong Jiang
- 1 October 2011
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 152 (4) , 678-685.e2
Abstract
No abstract availableKeywords
Funding Information
- The Study and Development Fund of The People's Hospital of Peking University (RDB2009-42)
- National Natural Science Foundation of China (30901639, 81041005)
- PhD Programs Foundation of the Ministry of Education of China (20100001110073)
- EFSD/CDS/Lilly
- Beijing Novel Program (2009B04)
This publication has 25 references indexed in Scilit:
- Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal DiseasesPLOS ONE, 2009
- Soluble IL-6 Receptor in Vitreous Fluid of Patients with Proliferative Diabetic RetinopathyJapanese Journal of Ophthalmology, 2007
- Interaction between serum amyloid A and leukocytes—A possible role in the progression of vascular complications in diabetesImmunology Letters, 2007
- Interleukin‐6 Trans‐Signalling in Chronic Inflammation and CancerScandinavian Journal of Immunology, 2006
- Serum amyloid A production by chicken fibroblast-like synoviocytesVeterinary Immunology and Immunopathology, 2005
- Expression and Regulation of Constitutive and Acute Phase Serum Amyloid A mRNAs in Hepatic and Non‐Hepatic Cell LinesScandinavian Journal of Immunology, 1996
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Interleukin-6 and Its Receptor: A Paradigm for CytokinesScience, 1992
- Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytesFEBS Letters, 1988